Literature DB >> 13270444

The coagulation defect caused by tromexan therapy.

A S DOUGLAS.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION/effect of drugs on; COUMARIN/derivatives

Mesh：

Substances：

Year:  1955        PMID： 13270444

Source DB:  PubMed          Journal:  Clin Sci        ISSN： 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  4 in total

1.  A congenital blood-clotting anomaly resembling coumarin-induced defect.

Authors:  F NOUR-ELDIN; J F WILKINSON
Journal:  Br Med J       Date:  1959-05-02

2.  Hypoprothrombinaemia in the newborn.

Authors:  A S DOUGLAS; P DAVIES
Journal:  Arch Dis Child       Date:  1955-12       Impact factor: 3.791

3.  Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.

Authors:  C HOUGIE; E M BARROW; J B GRAHAM
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

4.  AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.

Authors:  C W BAUGH
Journal:  Can Med Assoc J       Date:  1965-01-16       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.